The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.
As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...
Xenon has promising Phase 2 data for MDD treatment, robust financials, and a potential in niche markets, despite premium ...
Gov. Newsom in 2020 signed a law allowing California to manufacture its own insulin, an effort to bring down the cost of the ...
Researchers have identified nine mutations in a bird flu strain from a person in Texas. Bad news: this strain is more capable of causing disease and replicates better in the brain. Good news: approved ...
CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...
The OIG report points to gaps in documentation and decision-making transparency, particularly in the case of Aduhelm, where FDA records indicated only 13 meetings with Biogen, but congressional ...
A state bill that could allow for synthetic psilocybin to be prescribed in Colorado cleared a key committee hearing on ...
Eli Lilly (NYSE:LLY) has received FDA approval for its drug Omvoh, also known as mirikizumab-mrkz, for the treatment of moderately to severely active Crohn's disease in adults. The drug was previously ...
Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn’s ...
Thousands of foods contain Red Dye No. 3, the substance banned by U.S. regulators on Wednesday due to potential cancer links.
The ban removes it from the list of approved color additives in foods, dietary supplements and oral medicines, such as cough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback